FeesSafety
Pluang+

Outset Medical to report Q3 2026 financial results on Nov 4 with CEO and CFO call.

Company Fundamentals
21 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
Outset Medical to report Q3 2026 financial results on Nov 4 with CEO and CFO call.

Outset Medical, a medical technology company specializing in dialysis solutions, will announce its third quarter 2026 financial results after market close on November 4, 2026. CEO Leslie Trigg and CFO Renee Gaeta will hold a conference call the same day to discuss the results. The company is known for its Tablo Hemodialysis System, which simplifies dialysis treatment and is used by over 1,000 U.S. healthcare facilities. Investors can access the call live or archived via the company's website.

Outset Medical's upcoming Q3 2026 financial results provide context for healthcare sector activity on Pluang. For readers following healthcare stocks, here is Pluang's market snapshot as of Oct 22, 2026 03:02 WIB: Among 150 priced health-sector US stocks, 73 rose and 75 fell. Notable movers include Charles River Laboratories Intl. Inc (CRL) at USD 344.63 with a 1-day change of +9.25% and 100% buy order activity, Liquidia Corporation (LQDA) at USD 38.98 with +7.24% but 91% sell order activity, and DexCom, Inc. (DXCM) at USD 79.99 with a -6.71% change and 100% sell order activity. Typical hold times vary from 2 to 62 days across these stocks.

More News

Bristol Myers Squibb outgrows Novo Nordisk in 2027 with rising revenue and net income despite pricing pressures.

Bristol Myers Squibb outgrows Novo Nordisk in 2027 with rising revenue and net income despite pricing pressures.

Bristol Myers Squibb is expected to grow revenue by 3% and net income by over 40% in 2027, benefiting from new growth brands and a strong pipeline despite challenges like pricing pressures and patent expirations. Novo Nordisk, while dominant in obesi...

Market News
Bullish
1 hour ago
Adding ETFs with overlapping holdings can reduce diversification benefits in your portfolio.

Adding ETFs with overlapping holdings can reduce diversification benefits in your portfolio.

Investors often buy ETFs for instant diversification, but adding multiple ETFs with similar holdings, like iShares Core S&P 500 ETF (IVV) and Vanguard S&P 500 ETF (VOO), may lead to significant overlap rather than true diversification. Both funds tra...

Market News
Neutral
1 hour ago
Nasdaq enters correction amid rapid sell-off; Nvidia plunges 32% after CEO resignation.

Nasdaq enters correction amid rapid sell-off; Nvidia plunges 32% after CEO resignation.

The Nasdaq Composite has dropped over 13% from its all-time high, entering a correction phase, with the Dow and S&P 500 also down significantly. Nvidia's stock fell 32% in three weeks following the unexpected resignation of its CEO Jensen Huang, rais...

Bearish
1 hour ago
S&P 500 volatility rises post-midterms, signaling uncertain market ahead with mixed historical returns.

S&P 500 volatility rises post-midterms, signaling uncertain market ahead with mixed historical returns.

Since the midterm elections, the S&P 500 has experienced increased volatility, falling about 10% from its all-time high. Historical data shows mixed outcomes after similar swings, with recent years seeing positive returns but earlier periods marked b...

Market News
Neutral
1 hour ago
CAVA's rapid growth challenges Lululemon's strong profits in consumer stock race for 2027.

CAVA's rapid growth challenges Lululemon's strong profits in consumer stock race for 2027.

CAVA Group is expanding quickly in the Mediterranean fast-casual market, showing 27% revenue growth and steady restaurant efficiency, while Lululemon Athletica maintains high profitability with $11.1 billion revenue and strong free cash flow. CAVA ap...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App